Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print February 21, 2007, doi:10.1212/01.wnl.0000258543.45879.f5)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
01.wnl.0000258543.45879.f5v1
68/13/1013    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernandez, A.
Right arrow Articles by Mayer, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandez, A.
Right arrow Articles by Mayer, S. A.
Received March 10, 2006
Accepted September 19, 2006

Fever after subarachnoid hemorrhage. Risk factors and impact on outcome

A. Fernandez MD, J. M. Schmidt PhD, J. Claassen MD, M. Pavlicova PhD, D. Huddleston MD, K. T. Kreiter PhD, N. D. Ostapkovich MS, R. G. Kowalski MS, A. Parra MD, E. Sander Connolly MD, and S. A. Mayer MD*

From the Neurological Intensive Care Unit, Division of Stroke and Critical Care, Department of Neurology (A.F., M.S., J.C., D.H., K.T.K., N.D.O., R.G.K., A.P., S.A.M.), and the Department of Neurosurgery (A.P., E.S.C., S.A.M.), College of Physicians and Surgeons; and the Department of Biostatistics (M.P.), Mailman School of Public Health, Columbia University, New York, NY.


* To whom correspondence should be addressed. E-mail: sam14{at}columbia.edu.

Abstract-- Objective: To identify risk factors for refractory fever after subarachnoid hemorrhage (SAH), and to determine the impact of temperature elevation on outcome. Methods: We studied a consecutive cohort of 353 patients with SAH with a maximum daily temperature (Tmax) recorded on at least 7 days between SAH days 0 and 10. Fever (>38.3 °C) was routinely treated with acetaminophen and conventional water-circulating cooling blankets. We calculated daily Tmax above 37.0 °C, and defined extreme Tmax as daily excess above 38.3 °C. Global outcome at 90 days was evaluated with the modified Rankin Scale (mRS), instrumental activities of daily living (IADLs) with the Lawton scale, and cognitive functioning with the Telephone Interview of Cognitive Status. Mixed-effects models were used to identify predictors of Tmax, and logistic regression models to evaluate the impact of Tmax on outcome. Results: Average daily Tmax was 1.15 °C (range 0.04 to 2.74 °C). The strongest predictors of fever were poor Hunt-Hess grade and intraventricular hemorrhage (IVH) (both p < 0.001). After controlling for baseline outcome predictors, daily Tmax was associated with an increased risk of death or severe disability (mRS ≥ 4, adjusted OR 3.0 per °C, 95% CI 1.6 to 5.8), loss of independence in IADLs (OR 2.6, 95% CI 1.2 to 5.6), and cognitive impairment (OR 2.5, 95% CI 1.2 to 5.1, all p ≤ 0.02). These associations were even stronger when extreme Tmax was analyzed. Conclusion: Treatment-refractory fever during the first 10 days after subarachnoid hemorrhage (SAH) is predicted by poor clinical grade and intraventricular hemorrhage, and is associated with increased mortality and more functional disability and cognitive impairment among survivors. Clinical trials are needed to evaluate the impact of prophylactic fever control on outcome after SAH.




This article has been cited by other articles:


Home page
StrokeHome page
M. Oddo, S. Frangos, A. Milby, I. Chen, E. Maloney-Wilensky, E. M. Murtrie, M. Stiefel, W. A. Kofke, P. D. Le Roux, and J. M. Levine
Induced Normothermia Attenuates Cerebral Metabolic Distress in Patients With Aneurysmal Subarachnoid Hemorrhage and Refractory Fever
Stroke, May 1, 2009; 40(5): 1913 - 1916.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. Badjatia, E. Strongilis, E. Gordon, M. Prescutti, L. Fernandez, A. Fernandez, M. Buitrago, J. M. Schmidt, N. D. Ostapkovich, and S. A. Mayer
Metabolic Impact of Shivering During Therapeutic Temperature Modulation: The Bedside Shivering Assessment Scale
Stroke, December 1, 2008; 39(12): 3242 - 3247.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. M. Dorhout Mees, M. J.A. Luitse, W. M. van den Bergh, and G. J.E. Rinkel
Fever After Aneurysmal Subarachnoid Hemorrhage: Relation With Extent of Hydrocephalus and Amount of Extravasated Blood
Stroke, July 1, 2008; 39(7): 2141 - 2143.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. J. Redekop
Prognostic Factors and Targets for Intervention After Subarachnoid Hemorrhage
Stroke, August 1, 2007; 38(8): 2217 - 2218.
[Full Text] [PDF]


Home page
JWatch NeurologyHome page
Predictors and Impact of Fever After Subarachnoid Hemorrhage
Journal Watch Neurology, July 10, 2007; 2007(710): 1 - 1.
[Full Text]


Home page
NeurologyHome page
G. S.F. Ling
More heat to treat fever in subarachnoid hemorrhage?
Neurology, March 27, 2007; 68(13): 973 - 974.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by AAN Enterprises, Inc.